Robert C. Low, Vice President & Acting CFO at ADVANCIS PHARMACEUTICAL CORP (AVNC), bought 5,300 shares at $1.80 ($9K) on 2006-02-24, disclosed to the SEC on 2006-02-24.
Open-market purchase of $9k AVNC by Vice President & Acting CFO. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.76 | 400 | $704 | 7.4% |
| 2 | $1.76 | 600 | $1K | 11.1% |
| 3 | $1.77 | 1,800 | $3K | 33.5% |
| 4 | $1.79 | 400 | $716 | 7.5% |
| 5 | $1.80 | 600 | $1K | 11.4% |
| 6 | $1.82 | 200 |
| $364 |
| 3.8% |
| 7 | $1.83 | 1 | $2 | 0.0% |
| 8 | $1.84 | 900 | $2K | 17.4% |
| 9 | $1.84 | 399 | $734 | 7.7% |
| Total | $1.79 avg | 5,300 | $9K | 100% |